Qualigen Therapeutics Stock News

CARLSBAD, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutic products for the treatment of cancer, as well as maintaining and expanding its flagship FastPack ® diagnostic platform, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 5,880,000 shares of the Companys common stock at a purchase price of $1.50 per share pursuant to a registered direct offering. The closing of the offering is expected to occur on or about December 1, 2021, subject to the satisfaction of customary closing conditions.

Qualigen Therapeutics, Inc. (QLGN) with the stream of -2.86% also noticed, India Virgin Galactic Holdings, Inc. (SPCE) encountered a rapid change of -1.76% in the last hour of trading session. The post Explosive Stock: Qualigen Therapeutics, Inc. (NASDAQ:QLGN), Virgin Galactic Holdings, Inc. (NYSE:SPCE) appeared first on Stocks Equity .

If you're making a penny stocks watchlist for December, check these three out The post Hot Penny Stocks to Add to Your Watchlist in December appeared first on Penny Stocks to Buy, Picks, News and Inf

If you're making a penny stocks watchlist for December, check these three out The post Hot Penny Stocks to Add to Your Watchlist in December appeared first on Penny Stocks to Buy, Picks, News and Info

Renaissance Technologies LLC purchased a new stake in shares of Qualigen Therapeutics, Inc. (NASDAQ:QLGN) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 113,911 shares of the companys stock, valued at approximately $227,000. Several other institutional investors have also recently bought and sold []

Qualigen Therapeutics Inc (QLGN) shares closed this week 85.9% higher than it did at the end of last week. The stock is currently down 41.9% year-to-date, down 49.4% over the past 12 months, and down 92.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $3.12 and as low as $0.93 this week.Trading volume this week was 28.5% lower than the 10-day average and 136.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 36.9% The company's stock price performance over the past 12 months lags the peer average by 104.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Vanguard Group Inc. raised its holdings in Qualigen Therapeutics, Inc. (NASDAQ:QLGN) by 239.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,023,911 shares of the companys stock after acquiring an additional 722,716 shares during the period. Vanguard Group Inc. owned approximately []

Here''s what investors may want to know about preclinical biotech firm Qualigen as QLGN stock absolutely skyrockets today.

Why investors are watching these top penny stocks right now The post Best Penny Stocks to Buy Right Now? 3 to Watch Next Month appeared first on Penny Stocks to Buy, Picks, News and Information | Pen

Why investors are watching these top penny stocks right now The post Best Penny Stocks to Buy Right Now? 3 to Watch Next Month appeared first on Penny Stocks to Buy, Picks, News and Information | Penn

Qualigen Therapeutics Inc (NASDAQ:QLGN) shares are trading higher after a Zack's Small Cap research note showed a $9 price target on the stock. The report is based on a probability-adjusted DCF model

The stock price of Qualigen Therapeutics Inc (NASDAQ: QLGN) increased by over 85% pre-market today. This is why it happened.

Are these penny stocks on your watchlist right now? The post Hot Penny Stocks to Buy Right Now? 3 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co

Are these penny stocks on your watchlist right now? The post Hot Penny Stocks to Buy Right Now?

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential